Apollomics net loss for six months ended June 30, 2026 narrows 30% to $8.77 million
APLM•Apollomics’ net loss narrowed 30% year over year to $8.77 million for the six months ended June 30, 2026, while revenue fell to zero from $8.5 million. Cash was $1.01 million at June 30, and management identified substantial doubt about the company’s ability to continue as a going concern.
1. First-half results
Apollomics reported a net loss of $8.77 million for the six months ended June 30, 2026, down 30% year over year, while revenue fell to nil from $8.5 million. Cash totaled $1.01 million at June 30, and management identified substantial doubt about the company’s ability to continue as a going concern. The company recorded a $2.3 million impairment to fully reserve the LaunXP receivable after nonpayment; the licensing agreement terminated effective June 11. An August 14 private placement generated approximately $8 million in cash proceeds and extinguished a $2 million convertible promissory note.
